These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 31226168)
1. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis. Morgan EL; Macdonald A PLoS Pathog; 2019 Jun; 15(6):e1007835. PubMed ID: 31226168 [TBL] [Abstract][Full Text] [Related]
2. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment. Ren C; Cheng X; Lu B; Yang G Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057 [TBL] [Abstract][Full Text] [Related]
3. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production. Hess S; Smola H; Sandaradura De Silva U; Hadaschik D; Kube D; Baldus SE; Flucke U; Pfister H J Immunol; 2000 Aug; 165(4):1939-48. PubMed ID: 10925276 [TBL] [Abstract][Full Text] [Related]
4. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. Morgan EL; Wasson CW; Hanson L; Kealy D; Pentland I; McGuire V; Scarpini C; Coleman N; Arthur JSC; Parish JL; Roberts S; Macdonald A PLoS Pathog; 2018 Apr; 14(4):e1006975. PubMed ID: 29630659 [TBL] [Abstract][Full Text] [Related]
5. The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma. Zhang J; Jiang M; Qian L; Lin X; Song W; Gao Y; Zhou Y Mol Oncol; 2020 Sep; 14(9):2313-2331. PubMed ID: 32491253 [TBL] [Abstract][Full Text] [Related]
6. STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes. Xiang M; Birkbak NJ; Vafaizadeh V; Walker SR; Yeh JE; Liu S; Kroll Y; Boldin M; Taganov K; Groner B; Richardson AL; Frank DA Sci Signal; 2014 Jan; 7(310):ra11. PubMed ID: 24473196 [TBL] [Abstract][Full Text] [Related]
7. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Shukla S; Shishodia G; Mahata S; Hedau S; Pandey A; Bhambhani S; Batra S; Basir SF; Das BC; Bharti AC Mol Cancer; 2010 Oct; 9():282. PubMed ID: 20977777 [TBL] [Abstract][Full Text] [Related]
8. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma. Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856 [TBL] [Abstract][Full Text] [Related]
9. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Miao JW; Liu LJ; Huang J Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843 [TBL] [Abstract][Full Text] [Related]
11. Activated Rac1 regulates the degradation of IκBα and the nuclear translocation of STAT3-NFκB complexes in starved cancer cells. Kim SJ; Yoon S Exp Mol Med; 2016 May; 48(5):e231. PubMed ID: 27151455 [TBL] [Abstract][Full Text] [Related]
14. Revisiting the role of endogenous STAT3 in HPV-positive cervical cancer cells. Strobel TD; Weber M; Heber N; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F J Med Virol; 2023 Nov; 95(11):e29230. PubMed ID: 38009614 [TBL] [Abstract][Full Text] [Related]
15. Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. Shukla S; Mahata S; Shishodia G; Pandey A; Tyagi A; Vishnoi K; Basir SF; Das BC; Bharti AC PLoS One; 2013; 8(7):e67849. PubMed ID: 23874455 [TBL] [Abstract][Full Text] [Related]
16. Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer. Kim L; Park SA; Park H; Kim H; Heo TH Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445405 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961 [TBL] [Abstract][Full Text] [Related]
18. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development. Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269 [TBL] [Abstract][Full Text] [Related]
20. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer. Morgan EL; Scarth JA; Patterson MR; Wasson CW; Hemingway GC; Barba-Moreno D; Macdonald A Cell Death Differ; 2021 May; 28(5):1669-1687. PubMed ID: 33303976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]